Avalon Globocare Corp
ALBT1.260USD
-0.020-1.56%
收盘 12/24, 13:00（美东）报价延迟15分钟
5.16M总市值
亏损市盈率 TTM
关于 Avalon Globocare Corp 公司
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Avalon Globocare Corp简介
公司代码ALBT
公司名称Avalon Globocare Corp
上市日期Feb 22, 2016
CEOJin (David)
员工数量5
证券类型Ordinary Share
年结日Feb 22
公司地址4400 Route 9
城市FREEHOLD
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07728
电话17327804400
网址https://www.avalon-globocare.com/
公司代码ALBT
上市日期Feb 22, 2016
CEOJin (David)
Avalon Globocare Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月20日 周四
更新时间: 11月20日 周四
持股股东
股东类型
持股股东
持股股东
占比
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
Geode Capital Management, L.L.C.
0.52%
其他
90.03%
持股股东
持股股东
占比
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
Geode Capital Management, L.L.C.
0.52%
其他
90.03%
股东类型
持股股东
占比
Individual Investor
8.87%
Investment Advisor
0.60%
Investment Advisor/Hedge Fund
0.52%
Hedge Fund
0.01%
其他
90.00%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
29
48.23K
1.25%
--
2025Q3
31
48.23K
1.39%
+17.57K
2025Q2
33
19.75K
2.15%
+2.84K
2025Q1
33
16.91K
2.05%
-16.99K
2024Q4
35
16.66K
2.06%
-67.00
2024Q3
33
16.73K
1.75%
-236.00
2024Q2
33
16.96K
1.41%
+10.31K
2024Q1
31
6.65K
1.69%
-5.84K
2023Q4
32
10.45K
1.58%
+1.42K
2023Q3
39
9.06K
1.97%
+456.00
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Lu (Wenzhao)
238.93K
6.23%
+9.00
+0.00%
Mar 31, 2025
Jin (David)
103.00K
2.69%
--
--
Mar 31, 2025
Li (Meng)
34.33K
0.9%
+1.00
+0.00%
Mar 31, 2025
The Vanguard Group, Inc.
1.58K
0.04%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
9.34K
0.24%
--
--
Aug 31, 2025
Tauzin (Wilbert J II)
1.04K
0.03%
+1.04K
--
Mar 31, 2025
Tower Research Capital LLC
241.00
0.01%
+241.00
--
Jun 30, 2025
Citi Investment Research (US)
951.00
0.02%
+951.00
--
Jun 30, 2025
BofA Global Research (US)
113.00
0%
+7.00
+6.60%
Jun 30, 2025
UBS Financial Services, Inc.
4.20K
0.11%
+1.64K
+64.05%
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
公告日期
类型
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
常见问题
Avalon Globocare Corp的前五大股东是谁？
Avalon Globocare Corp 的前五大股东如下：
Lu (Wenzhao)持有股份：238.93K，占总股份比例：6.23%。
Jin (David)持有股份：103.00K，占总股份比例：2.69%。
Li (Meng)持有股份：34.33K，占总股份比例：0.90%。
The Vanguard Group, Inc.持有股份：1.58K，占总股份比例：0.04%。
Geode Capital Management, L.L.C.持有股份：9.34K，占总股份比例：0.24%。
Lu (Wenzhao)持有股份：238.93K，占总股份比例：6.23%。
Jin (David)持有股份：103.00K，占总股份比例：2.69%。
Li (Meng)持有股份：34.33K，占总股份比例：0.90%。
The Vanguard Group, Inc.持有股份：1.58K，占总股份比例：0.04%。
Geode Capital Management, L.L.C.持有股份：9.34K，占总股份比例：0.24%。
Avalon Globocare Corp的前三大股东类型是什么？
Avalon Globocare Corp 的前三大股东类型分别是：
Lu (Wenzhao)
Jin (David)
Li (Meng)
Lu (Wenzhao)
Jin (David)
Li (Meng)
有多少机构持有Avalon Globocare Corp(ALBT)的股份？
截至2025Q4，共有29家机构持有Avalon Globocare Corp的股份，合计持有的股份价值约为48.23K，占公司总股份的1.25%。与2025Q3相比，机构持股有所增加，增幅为-0.14%。
哪个业务部门对Avalon Globocare Corp的收入贡献最大？
在--，--业务部门对Avalon Globocare Corp的收入贡献最大，创收--，占总收入的--%。
